Search
for
Sort by
Research 121–150 of 1000+
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Drug-Induced Skin, Nail and Hair Disorders
- GC-MS Analysis and Phytochemical Screening of Indigofera tinctoria (Linn.) Leaf Extract Characterizing its Medicinal Use
- Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Mucocutaneous reactions to chemotherapy
- Cutaneous complications of chemotherapeutic agents
- Adverse effects of common medications on male fertility
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Trends in Nanotechnology for Practical Applications
- Chemotherapy-Induced Alopecia
- Cytostatics and immunosuppressive drugs
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Drug Reactions Affecting Hair: Diagnosis
- Madarosis and facial keratinaceous spines
- 213P Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trial
- Cancer Chemotherapy: an Introduction
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- Intelligent nanotherapeutic strategies for the delivery of CRISPR system
- Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- Drug-induced scarring and permanent alopecia
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia